Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Sequence Similarity between Commensal Bifidobacterium and Cytotoxic T Lymphocyte Epitope Peptides against Human Tumor-Associated Antigens

Version 1 : Received: 10 October 2023 / Approved: 10 October 2023 / Online: 10 October 2023 (08:31:28 CEST)

How to cite: Itoh, K.; Shichijo, S.; Suekane, S. Sequence Similarity between Commensal Bifidobacterium and Cytotoxic T Lymphocyte Epitope Peptides against Human Tumor-Associated Antigens. Preprints 2023, 2023100598. https://doi.org/10.20944/preprints202310.0598.v1 Itoh, K.; Shichijo, S.; Suekane, S. Sequence Similarity between Commensal Bifidobacterium and Cytotoxic T Lymphocyte Epitope Peptides against Human Tumor-Associated Antigens. Preprints 2023, 2023100598. https://doi.org/10.20944/preprints202310.0598.v1

Abstract

The precise molecular basis of anti-tumor immunity is not yet fully understood, although commensal Bifidobacterium (c-BIF) is expected to be one of the key players in cancer control via antigenic mimicry. We investigated the sequence similarity between c-BIF and cytotoxic T lymphocyte (CTL) epitope peptides against human tumor-associated antigens to better understand the molecular basis of antigenic mimicry. We used two different similarity analyses for this purpose, a linear sequence analysis and a similarity analysis of T cell receptor (TCR)-mediated recognition of CTL epitope peptides on antigen-presenting cells. The linear sequence analysis revealed 3,900 positive numbers of similarity sites between them with 126 mean per peptide and 107 median per peptide, while the TCR-mediated recognition analysis revealed 5,018 positive numbers with a mean of 162 and median of 132 per peptide. These results demonstrated the existence of durable and abundant sequence similarities between c-BIF and CTL epitope peptides, suggesting that the former play a pivotal in inducing cellular and humoral immunity against the latter in the absence of cancer cells via antigenic mimicry.

Keywords

anti-tumor immunity; antigenic mimicry; CTL epitope peptides; human tumor-associated antigens; intestinal microbiota; linear sequence analysis; TCR-mediated recognition analysis

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.